Comparison of unmobilized and mobilized graft characteristics and the implications of cell subsets on autologous and allogeneic transplantation outcomes.
about
Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes.Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent.Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.Importance of blood graft characteristics in auto-SCT: implications for optimizing mobilization regimens.Novel strategies for blood stem cell mobilization: special focus on plerixafor.The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target?Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept.Current clinical indications for plerixaforPlerixafor injection: a hematopoietic stem cell mobilizer in non-Hodgkin lymphoma and multiple myeloma.New strategies for stem cell mobilization.Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients.Blood graft composition after plerixafor injection in patients with NHL.CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients.Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients.Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma.The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.
P2860
Q26773952-58AA674D-F86F-4351-9F72-A7A26A3CFEBDQ35041174-A1FB7CFF-D077-4F75-8314-193750C963BCQ35544484-31DEAB6C-A5F6-4018-BBC0-28C9C4AAA27EQ36445393-EC69B168-F480-4754-9CA4-55A9EBADCD13Q37827058-0BB34CAB-BCA7-42A4-B736-BEA186678835Q37909447-D9A4AE5E-B0CA-4536-BC52-8366F9560A0DQ37937045-D535D104-BC96-4EF4-9D36-4CA1DE6F7E3BQ37943423-234C200D-45F3-4BF7-A9B4-DE6D2747070AQ38177784-864B77C2-8F61-4C11-B99A-4A69B2F017BEQ38880504-B424389A-9F52-4E67-857D-6843220789D8Q41104670-7B453C60-3D51-482A-8D1C-665767EA7C7CQ43524297-9F018019-78F2-441F-A9D5-8036EAD57604Q44353274-CC00706F-A0A5-44C8-B631-992B82BD39F3Q47256928-28763116-9FB0-460F-8CCB-8C3D37CBEBB3Q50703524-2B8060DC-0FF7-4441-A9B0-A677358E897FQ52859049-7A07DE6E-6626-48F0-9081-3DAC740BD437Q53153100-93AE1B2A-C549-439A-8CAF-EE1FBCF2B46C
P2860
Comparison of unmobilized and mobilized graft characteristics and the implications of cell subsets on autologous and allogeneic transplantation outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of unmobilized and ...... neic transplantation outcomes.
@en
Comparison of unmobilized and ...... neic transplantation outcomes.
@nl
type
label
Comparison of unmobilized and ...... neic transplantation outcomes.
@en
Comparison of unmobilized and ...... neic transplantation outcomes.
@nl
prefLabel
Comparison of unmobilized and ...... neic transplantation outcomes.
@en
Comparison of unmobilized and ...... neic transplantation outcomes.
@nl
P1476
Comparison of unmobilized and ...... neic transplantation outcomes.
@en
P2093
Guido Tricot
Stefan Fruehauf
P304
P356
10.1016/J.BBMT.2010.02.002
P577
2010-02-07T00:00:00Z